Publications by authors named "Chul H Yu"

Claim this Profile
D
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.
Min Zhong, Thomas R Gadek, Minna Bui, Wang Shen, John Burnier, Chul H Yu

ACS Med Chem Lett· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.
Min Zhong, Emily J Hanan, Wang Shen, Minna Bui, Michelle R Arkin, Chul H Yu

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists.
Min Zhong, Wang Shen, Kenneth J Barr, Jennifer P Arbitrario, Michelle R Arkin, Chul H Yu

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Aminobenzimidazoles as potent Aurora kinase inhibitors.
Min Zhong, Minna Bui, Wang Shen, Subramanian Baskaran, Darin A Allen, Chul H Yu

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Water-soluble prodrugs of an Aurora kinase inhibitor.
Johan D Oslob, Stacey A Heumann, Chul H Yu, Darin A Allen, Subramanian Baskaran

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent and selective aurora kinase inhibitor.
Johan D Oslob, Michael J Romanowski, Darin A Allen, Subramanian Baskaran, Minna Bui, Chul H Yu

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of nonpeptidic small-molecule inhibitors of interleukin-2.
Nathan D Waal, Wenjin Yang, Johan D Oslob, Michelle R Arkin, Jennifer Hyde, Chul H Yu

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions.
Brian C Raimundo, Johan D Oslob, Andrew C Braisted, Jennifer Hyde, Robert S McDowell, Chul H Yu

J Med Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazolone p38 inhibitors.
Mark A Dombroski, Michael A Letavic, Kim F McClure, John T Barberia, Thomas J Carty, Chul H Yu

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.
Michael A Letavic, John T Barberia, Thomas J Carty, Joel R Hardink, Jennifer Liras, Chul H Yu

Bioorg Med Chem Lett· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitors.
Michael A Letavic, Matt Z Axt, John T Barberia, Thomas J Carty, Dennis E Danley, Chul H Yu

Bioorg Med Chem Lett· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis